ReviewInternational journal of molecular sciences2023

Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate.

Pilar Pizcueta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.